|
1
|
Ng KK, Poon RT, Lo CM, Yuen J, Tso WK and
Fan ST: Analysis of recurrence pattern and its influence on
survival outcome after radiofrequency ablation of hepatocellular
carcinoma. J Gastrointest Surg. 12:183–191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kudo M: Radiofrequency ablation for
hepatocellular carcinoma: updated review in 2010. Oncology.
78(Suppl 1): 113–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tiong L and Maddern GJ: Systematic review
and meta-analysis of survival and disease recurrence after
radiofrequency ablation for hepatocellular carcinoma. Br J Surg.
98:1210–1224. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Livraghi T, Meloni F, Di Stasi M, et al:
Sustained complete response and complications rates after
radiofrequency ablation of very early hepatocellular carcinoma in
cirrhosis: Is resection still the treatment of choice? Hepatology.
47:82–89. 2008. View Article : Google Scholar
|
|
5
|
Naugler WE and Sonnenberg A: Survival and
cost-effectiveness analysis of competing strategies in the
management of small hepatocellular carcinoma. Liver Transpl.
16:1186–1194. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Veltri A, Guarnieri T, Gazzera C, et al:
Long-term outcome of radiofrequency thermal ablation (RFA) of liver
metastases from colorectal cancer (CRC): size as the leading
prognostic factor for survival. Radiol Med. 117:1139–1151. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tombesi P, Di Vece F and Sartori S:
Resection vs thermal ablation of small hepatocellular carcinoma:
What’s the first choice? World J Radiol. 5:1–4. 2013.PubMed/NCBI
|
|
8
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases. Management of
hepatocellular carcinoma: an update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choi D, Lim HK, Rhim H, et al:
Percutaneous radiofrequency ablation for early-stage hepatocellular
carcinoma as a first-line treatment: long-term results and
prognostic factors in a large single-institution series. Eur
Radiol. 17:684–692. 2007. View Article : Google Scholar
|
|
10
|
Kim YS, Lim HK, Rhim H, et al: Ten-year
outcomes of percutaneous radiofrequency ablation as first-line
therapy of early hepatocellular carcinoma: analysis of prognostic
factors. J Hepatol. 58:89–97. 2013.PubMed/NCBI
|
|
11
|
Kariyama K, Nouso K, Wakuta A, et al:
Percutaneous radiofrequency ablation for treatment of
hepatocellular carcinoma in the caudate lobe. AJR Am J Roentgenol.
197:W571–575. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang Z, Fang H, Kang M, et al:
Percutaneous radiofrequency ablation for liver tumors: Is it safer
and more effective in low-risk areas than in high-risk areas?
Hepatol Res. 41:635–640. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang HW: Influence of blood vessel on the
thermal lesion formation during radiofrequency ablation for liver
tumors. Med Phys. 40:0733032013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morimoto M, Numata K, Kondo M, et al:
Radiofrequency ablation combined with transarterial
chemoembolization for subcapsular hepatocellular carcinoma: a
prospective cohort study. Eur J Radiol. 82:497–503. 2013.
View Article : Google Scholar
|
|
15
|
Sato M, Tateishi R, Yasunaga H, et al:
Mortality and morbidity of hepatectomy, radiofrequency ablation,
and embolization for hepatocellular carcinoma: a national survey of
54,145 patients. J Gastroenterol. 47:1125–1133. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo WX, Sun JX, Cheng YQ, et al:
Percutaneous radiofrequency ablation versus partial hepatectomy for
small centrally located hepatocellular carcinoma. World J Surg.
37:602–607. 2013. View Article : Google Scholar
|
|
17
|
Peng ZW, Lin XJ, Zhang YJ, et al:
Radiofrequency ablation versus hepatic resection for the treatment
of hepatocellular carcinomas 2 cm or smaller: a retrospective
comparative study. Radiology. 262:1022–1033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stang A, Fischbach R, Teichmann W,
Bokemeyer C and Braumann D: A systematic review on the clinical
benefit and role of radiofrequency ablation as treatment of
colorectal liver metastases. Eur J Cancer. 45:1748–1756. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wong SL, Mangu PB, Choti MA, et al:
American Society of Clinical Oncology 2009 clinical evidence review
on radiofrequency ablation of hepatic metastases from colorectal
cancer. J Clin Oncol. 28:493–508. 2010. View Article : Google Scholar : PubMed/NCBI
|
